- Home
- PEBK vs ACHV Comparison
PEBK vs ACHV Comparison
Compare PEBK & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEBK
- ACHV
- Stock Information
- Founded
- PEBK 1912
- ACHV N/A
- Country
- PEBK United States
- ACHV United States
- Employees
- PEBK N/A
- ACHV N/A
- Industry
- PEBK Major Banks
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PEBK Finance
- ACHV Health Care
- Exchange
- PEBK Nasdaq
- ACHV Nasdaq
- Market Cap
- PEBK 155.1M
- ACHV 131.2M
- IPO Year
- PEBK N/A
- ACHV N/A
- Fundamental
- Price
- PEBK $30.50
- ACHV $2.50
- Analyst Decision
- PEBK
- ACHV Strong Buy
- Analyst Count
- PEBK 0
- ACHV 3
- Target Price
- PEBK N/A
- ACHV $14.33
- AVG Volume (30 Days)
- PEBK 7.2K
- ACHV 670.2K
- Earning Date
- PEBK 07-21-2025
- ACHV 08-07-2025
- Dividend Yield
- PEBK 3.16%
- ACHV N/A
- EPS Growth
- PEBK 4.77
- ACHV N/A
- EPS
- PEBK 3.11
- ACHV N/A
- Revenue
- PEBK $84,131,000.00
- ACHV N/A
- Revenue This Year
- PEBK N/A
- ACHV N/A
- Revenue Next Year
- PEBK N/A
- ACHV N/A
- P/E Ratio
- PEBK $9.92
- ACHV N/A
- Revenue Growth
- PEBK 6.23
- ACHV N/A
- 52 Week Low
- PEBK $23.74
- ACHV $1.84
- 52 Week High
- PEBK $33.31
- ACHV $5.31
- Technical
- Relative Strength Index (RSI)
- PEBK 65.38
- ACHV 44.14
- Support Level
- PEBK $27.71
- ACHV $2.37
- Resistance Level
- PEBK $28.50
- ACHV $2.56
- Average True Range (ATR)
- PEBK 0.76
- ACHV 0.12
- MACD
- PEBK 0.14
- ACHV -0.00
- Stochastic Oscillator
- PEBK 100.00
- ACHV 34.21
About PEBK Peoples Bancorp of North Carolina Inc.
Peoples Bancorp of North Carolina Inc is a bank holding company. It is a state-chartered commercial bank serving Lincolnton, Newton, Denver, Catawba, Conover, Maiden, Claremont, Hiddenite, Hickory, Charlotte, Cornelius, Raleigh and Cary, North Carolina. It has a diversified loan portfolio with no foreign loans and few agricultural loans. The company's main source of income is dividends declared and paid by the Bank on its capital stock.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.